Mammary development

Parental factors that impact the ecology of human mammary development, milk secretion, and milk composition-a report from "Breastmilk Ecology: Genesis of Infant Nutrition (BEGIN)" Working Group 1

The goal of Working Group 1 in the Breastmilk Ecology: Genesis of Infant Nutrition (BEGIN) Project was to outline factors influencing biological processes governing human milk secretion and to evaluate our current knowledge of these processes. Many factors regulate mammary gland development in utero, during puberty, in pregnancy, through secretory activation, and at weaning. These factors include breast anatomy, breast vasculature, diet, and the lactating parent's hormonal milieu including estrogen, progesterone, placental lactogen, cortisol, prolactin, and growth hormone. We examine the effects of time of day and postpartum interval on milk secretion, along with the role and mechanisms of lactating parent-infant interactions on milk secretion and bonding, with particular attention to the actions of oxytocin on the mammary gland and the pleasure systems in the brain. We then consider the potential effects of clinical conditions including infection, pre-eclampsia, preterm birth, cardiovascular health, inflammatory states, mastitis, and particularly, gestational diabetes and obesity. Although we know a great deal about the transporter systems by which zinc and calcium pass from the blood stream into milk, the interactions and cellular localization of transporters that carry substrates such as glucose, amino acids, copper, and the many other trace metals present in human milk across plasma and intracellular membranes require more research. We pose the question of how cultured mammary alveolar cells and animal models can help answer lingering questions about the mechanisms and regulation of human milk secretion. We raise questions about the role of the lactating parent and the infant microbiome and the immune system during breast development, secretion of immune molecules into milk, and protection of the breast from pathogens. Finally, we consider the effect of medications, recreational and illicit drugs, pesticides, and endocrine-disrupting chemicals on milk secretion and composition, emphasizing that this area needs much more research attention.

Prepuberal ovine mammary development is unaffected by ovariectomy

Crossbred ewe lambs were used in a 2 x 2 x 2 factorial design to determine the effect of ovariectomy, age, and estrogen administration on prepuberal mammary development. Intact (I, n = 20) and ovariectomized (OVX, n = 17) lambs were sacrificed at 6 and 13 wk of age after 1 wk of either estrogen 0.1 mg/kg BW/day, s.c.) or vehicle injections. Ovaiectomies were performed at 10 +/- 1 d of age. At sacrifice, one mammary gland was dissected into parenchymal and stromal fractions for biochemical analyses. Parenchymal explants from the remaining gland were labeled with [3H]thymidine for histoautoradiography. Neither ovariectomy nor estrogen treatment affected body weight, total gland weight, or parenchymal weight (P > 0.05). However, means for each of these variables increased between 6 and 13 wk (P < 0.01). Analysis of relative mammary growth showed significant positive deviations from isometry. However, no significant difference in parenchymal allometry was observed between I and OVX groups. Exogenous estrogen stimulated an increase (P < 0.05) in epithelial cell labeling with [3H]thymidine, but neither ovariectomy nor age at sacrifice had any effect (P > 0.2) on epithelial labeling. These results demonstrate that prepuberal allometric mammary growth in the ewe lamb does not require the presence of the ovary.

Estrogen upregulation of BRCA1 expression with no effect on localization

Alterations in the expression of the breast and ovarian cancer susceptibility gene BRCA1 may contribute to the development of mammary and ovarian neoplasia. The sex-steroid estrogen modulates cell proliferation of normal and neoplastic breast and ovarian epithelial cells, but the role of estrogen regulation on the expression of BRCA1 remains to be defined. In this study, estrogen-regulated BRCA1 expression was examined in breast and ovarian cancer cells. Estrogen stimulated the proliferation of estrogen receptor (ER)-positive breast MCF-7, C7-MCF-7, and ovarian BG-1 cells as well as the expression of the estrogen-inducible pS2 gene. This was concomitant with upregulation of BRCA1 mRNA (2.5- to 5.0-fold) and a 3- to 10-fold induction of BRCA1 protein (230 kDa). Cell fractionation studies localized the BRCA1 protein to the nucleus in both unstimulated and estrogen-stimulated cells. The antiestrogen ICI-182780 inhibited estrogen-induced cell proliferation, BRCA1 mRNA induction, and BRCA1 protein expression in ER-positive cells. Conversely, estrogen did not influence expression of BRCA1 in HBL-100 cells that lacked the estrogen receptor, although the constitutive levels of BRCA1 mRNA (but not protein) in these cells were 5- to 30-fold higher than in other breast and ovarian cancer cells. Secretion of the BRCA1 protein into the cell medium did not account for the discrepancy between the mRNA and protein levels in HBL-100 cells. Proliferation of HBL-100 cells was not affected by either estrogen or ICI-182780. Taken together, these data support a role for the steroid estrogen and the involvement of the estrogen receptor pathway in the modulation of expression of BRCA1. We therefore propose that stimulation of cell proliferation may be a prerequisite for upregulation of BRCA1 in breast and ovarian cancer cells.

The effect of manipulation in energy allowance during the rearing period of heifers on hormone concentrations and milk production in first lactation cows

Fifteen Holstein heifers that were 175 +/- 4.0 d old and at BW of 175 +/- 4.9 kg were used to determine the effect of three feeding regimens from 6 to 12 mo of age on growth, blood concentration of several hormones, and milk production during first lactation. The feeding regimens consisted of two periods, the first lasting for 4 mo and the other for the subsequent 2 mo. For group A (restricted) heifers, the diet during period 1 was restricted to 85% of NRC (1988) recommendations (a daily BW gain of .7 kg); during period 2, a high energy, high protein diet was provided for ad libitum intake. Group B (control) heifers received a diet that corresponded to 100 and 90% of the NRC (1988) recommendations in periods 1 and 2, respectively. Group C (ad libitum) intake heifers received a high energy, high protein diet throughout both periods. Daily BW gains of heifers of groups A, B, and C were, respectively, .625, .768, and 1.100 kg for period 1 and 1.162, .705, and .797 kg for period 2. The different feeding regimens influenced the age at which the heifers achieved puberty but did not affect BW at puberty. Milk production during 250 d of lactation was 7056, 6070, and 5975 kg for groups A, B, and C, respectively. A statistical model that included serum derived mitogenic activity and serum prolactin of period 2 accounted for 63% of the difference in milk production at first lactation.